Burn wound healing and treatment: Review and advancements

Critical Care

Volumn 19, Issue 1, 2015, Pages

  Rowan, Matthew P ^a   Cancio, Leopoldo C ^a   Elster, Eric A ^b   Burmeister, David M ^a   Rose, Lloyd F ^a   Natesan, Shanmugasundaram ^a   Chan, Rodney K ^a,c   Christy, Robert J ^a   Chung, Kevin K ^a,b  

^a US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; MAFENIDE; MORPHINE; SULFADIAZINE; BIOLOGICAL MARKER;

APOPTOSIS; BODY SURFACE; BURN; BURN INFECTION; CAPILLARY PERMEABILITY; CARBOHYDRATE INTAKE; CELL PROLIFERATION; DISEASE SEVERITY; EPITHELIZATION; HEART OUTPUT; HUMAN; HYDROGEL; HYDROSTATIC PRESSURE; HYPOVOLEMIA; IMMUNE STATUS; INFLAMMATION; KERATINOCYTE; LENGTH OF STAY; MORTALITY; MYOFIBROBLAST; NUTRITIONAL ASSESSMENT; OSMOSIS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PATIENT CARE; PHENOTYPE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVIEW; SKIN ALLOGRAFT; SKIN TRANSPLANTATION; URINE VOLUME; WOUND CARE; WOUND DRESSING; WOUND HEALING; ARTIFICIAL SKIN; BANDAGE; BURNS; COMPLICATION; DIAGNOSTIC IMAGING; EDEMA; FLUID THERAPY; NUTRITIONAL SUPPORT; OBESITY; PHYSIOLOGY; RESUSCITATION; STEM CELL TRANSPLANTATION; TRANSPLANTATION; WOUND INFECTION;

BANDAGES; BIOMARKERS; BURNS; DIAGNOSTIC IMAGING; EDEMA; FLUID THERAPY; HUMANS; INFLAMMATION; KERATINOCYTES; NUTRITIONAL SUPPORT; OBESITY; RESUSCITATION; SKIN TRANSPLANTATION; SKIN, ARTIFICIAL; STEM CELL TRANSPLANTATION; WOUND HEALING; WOUND INFECTION;

EID: 84931266595     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-015-0961-2     Document Type: Review

References (202)

1. Gibran NS, Wiechman S, Meyer W, Edelman L, Fauerbach J, Gibbons L, et al. American Burn Association consensus statements. J Burn Care Res. 2013;34:361-5.
2. Mann R, Heimbach D. Prognosis and treatment of burns. West J Med. 1996;165:215-20.
3. American Burn Association. Burn incidence and treatment in the United States: 2013 fact sheet. 2013. http://www.ameriburn.org/resources_factsheet.php . Accessed 12 May 2015.
4. Sen S, Palmieri T, Greenhalgh D. Review of burn research for the year 2013. J Burn Care Res. 2014;35:362-8.
5. Wolf SE, Arnoldo BD. The year in burns 2011. Burns. 2012;38:1096-108.
6. Burd A. Research in burns - present and future. Indian J Plast Surg. 2010;43:S11-4.
7. Thomas SJ, Kramer GC, Herndon DN. Burns: military options and tactical solutions. J Trauma. 2003;54:S207-18.
8. American Burn Association. National Burn Repository 2014. 2014. http://www.ameriburn.org/2014NBRAnnualReport.pdf . Accessed 12 May 2015.
9. Kagan RJ, Peck MD, Ahrenholz DH, Hickerson WL, Holmes J, Korentager R, et al. Surgical management of the burn wound and use of skin substitutes: an expert panel white paper. J Burn Care Res. 2013;34:e60-79.
10. Nisanci M, Eski M, Sahin I, Ilgan S, Isik S. Saving the zone of stasis in burns with activated protein C: an experimental study in rats. Burns. 2010;36:397-402.
11. Robins EV. Burn shock. Crit Care Nurs Clin North Am. 1990;2:299-307.
12. Pham TN, Cancio LC, Gibran NS, American Burn Association. American Burn Association practice guidelines burn shock resuscitation. J Burn Care Res. 2008;29:257-66.
13. Shirani KZ, Vaughan GM, Mason Jr. AD, Pruitt Jr. BA. Update on current therapeutic approaches in burns. Shock. 1996;5:4-16.
14. Dries DJ. Management of burn injuries - recent developments in resuscitation, infection control and outcomes research. Scand J Trauma Resusc Emerg Med. 2009;17:14.
15. Porter C, Hurren NM, Herndon DN, Borsheim E. Whole body and skeletal muscle protein turnover in recovery from burns. Int J Burns Trauma. 2013;3:9-17.
16. Farina Jr. JA, Rosique MJ, Rosique RG. Curbing inflammation in burn patients. Int J Inflamm. 2013;2013:715645.
17. Edgar DW, Fish JS, Gomez M, Wood FM. Local and systemic treatments for acute edema after burn injury: a systematic review of the literature. J Burn Care Res. 2011;32:334-47.
18. Sommer K, Sander AL, Albig M, Weber R, Henrich D, Frank J, et al. Delayed wound repair in sepsis is associated with reduced local pro-inflammatory cytokine expression. PLoS One. 2013;8, e73992.
19. Wilmore DW, Long JM, Mason Jr. AD, Skreen RW, Pruitt Jr BA. Catecholamines: mediator of the hypermetabolic response to thermal injury. Ann Surg. 1974;180:653-69.
20. Sakallioglu AE, Basaran O, Karakayali H, Ozdemir BH, Yucel M, Arat Z, et al. Interactions of systemic immune response and local wound healing in different burn depths: an experimental study on rats. J Burn Care Res. 2006;27:357-66.
21. Pereira CT, Herndon DN. The pharmacologic modulation of the hypermetabolic response to burns. Adv Surg. 2005;39:245-61.
22. Hussain A, Dunn KW. Predicting length of stay in thermal burns: a systematic review of prognostic factors. Burns. 2013;39:1331-40.
23. Colohan SM. Predicting prognosis in thermal burns with associated inhalational injury: a systematic review of prognostic factors in adult burn victims. J Burn Care Res. 2010;31:529-39.
24. Jackson DM. The diagnosis of the depth of burning. Br J Surg. 1953;40:588-96.
25. Hettiaratchy S, Dziewulski P. ABC of burns: pathophysiology and types of burns. BMJ. 2004;328:1427-9.
26. Kowalske KJ. Burn wound care. Phys Med Rehab Clin North Am. 2011;22:213-27.
27. Tan JQ, Zhang HH, Lei ZJ, Ren P, Deng C, Li XY, et al. The roles of autophagy and apoptosis in burn wound progression in rats. Burns. 2013;39:1551-6.
28. Singer AJ, McClain SA, Taira BR, Guerriero JL, Zong W. Apoptosis and necrosis in the ischemic zone adjacent to third degree burns. Acad Emerg Med. 2008;15:549-54.
29. Matylevitch NP, Schuschereba ST, Mata JR, Gilligan GR, Lawlor DF, Goodwin CW, et al. Apoptosis and accidental cell death in cultured human keratinocytes after thermal injury. Am J Pathol. 1998;153:567-77.
30. Deniz M, Borman H, Seyhan T, Haberal M. An effective antioxidant drug on prevention of the necrosis of zone of stasis: N-acetylcysteine. Burns. 2013;39:320-5.
31. Tiwari VK. Burn wound: how it differs from other wounds? Indian J Plast Surg. 2012;45:364-73.
32. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453:314-21.
33. Reinke JM, Sorg H. Wound repair and regeneration. Eur Surg Res. 2012;49:35-43.
34. Werner S, Krieg T, Smola H. Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol. 2007;127:998-1008.
35. Pastar I, Stojadinovic O, Yin NC, Ramirez H, Nusbaum AG, Sawaya A, et al. Epithelialization in wound healing: a comprehensive review. Adv Wound Care. 2014;3:445-64.
36. Widgerow AD. Cellular/extracellular matrix cross-talk in scar evolution and control. Wound Repair Regen. 2011;19:117-33.
37. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999;341:738-46.
38. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol. 2007;127:526-37.
39. Snowden JM. Wound closure: an analysis of the relative contributions of contraction and epithelialization. J Surg Res. 1984;37:453-63.
40. Shih B, Garside E, McGrouther DA, Bayat A. Molecular dissection of abnormal wound healing processes resulting in keloid disease. Wound Repair Regen. 2010;18:139-53.
41. Claudinot S, Nicolas M, Oshima H, Rochat A, Barrandon Y. Long-term renewal of hair follicles from clonogenic multipotent stem cells. Proc Natl Acad Sci U S A. 2005;102:14677-82.
42. Ito M, Liu Y, Yang Z, Nguyen J, Liang F, Morris RJ, et al. Stem cells in the hair follicle bulge contribute to wound repair but not to homeostasis of the epidermis. Nat Med. 2005;11:1351-4.
43. Curran TA, Ghahary A. Evidence of a role for fibrocyte and keratinocyte-like cells in the formation of hypertrophic scars. J Burn Care Res. 2013;34:227-31.
44. Tabas I, Glass CK. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science. 2013;339:166-72.
45. Arturson G. Forty years in burns research - the postburn inflammatory response. Burns. 2000;26:599-604.
46. Szpaderska AM, DiPietro LA. Inflammation in surgical wound healing: friend or foe? Surgery. 2005;137:571-3.
47. Franz MG, Steed DL, Robson MC. Optimizing healing of the acute wound by minimizing complications. Curr Probl Surg. 2007;44:691-763.
48. Stubhaug A, Romundstad L, Kaasa T, Breivik H. Methylprednisolone and ketorolac rapidly reduce hyperalgesia around a skin burn injury and increase pressure pain thresholds. Acta Anaesthesiol Scand. 2007;51:1138-46.
49. Huang G, Liang B, Liu G, Liu K, Ding Z. Low dose of glucocorticoid decreases the incidence of complications in severely burned patients by attenuating systemic inflammation. J Crit Care. 2015;30:e7-11.
50. Janzekovic Z. A new concept in the early excision and immediate grafting of burns. J Trauma. 1970;10:1103-8.
51. Orgill DP. Excision and skin grafting of thermal burns. N Engl J Med. 2009;360:893-901.
52. Barret JP, Herndon DN. Effects of burn wound excision on bacterial colonization and invasion. Plast Reconstruct Surg. 2003;111:744-50. discussion 751-2.
53. Cramer LM, McCormack CR, Carroll DB. Progressive partial excision and early graftin in lethal burns. Plast Reconstruct Surg Transplant Bull. 1962;30:595-9.
54. Engrav LH, Heimbach DM, Reus JL, Harnar TJ, Marvin JA. Early excision and grafting vs. nonoperative treatment of burns of indeterminant depth: a randomized prospective study. J Trauma. 1983;23:1001-4.
55. Stein C, Kuchler S. Non-analgesic effects of opioids: peripheral opioid effects on inflammation and wound healing. Curr Pharm Des. 2012;18:6053-69.
56. Brack A, Rittner HL, Stein C. Immunosuppressive effects of opioids - clinical relevance. J Neuroimmune Pharmacol. 2011;6:490-502.
57. Rook JM, Hasan W, McCarson KE. Morphine-induced early delays in wound closure: involvement of sensory neuropeptides and modification of neurokinin receptor expression. Biochem Pharmacol. 2009;77:1747-55.
58. Rook JM, McCarson KE. Delay of cutaneous wound closure by morphine via local blockade of peripheral tachykinin release. Biochem Pharmacol. 2007;74:752-7.
59. Bigliardi PL, Buchner S, Rufli T, Bigliardi-Qi M. Specific stimulation of migration of human keratinocytes by mu-opiate receptor agonists. J Recept Signal Transduct Res. 2002;22:191-9.
60. Stein C, Kuchler S. Targeting inflammation and wound healing by opioids. Trends Pharmacol Sci. 2013;34:303-12.
61. Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006;19:403-34.
62. Teplitz C, Davis D, Walker HL, Raulston GL, Mason Jr AD, Moncrief JA. Pseudomonas burn wound sepsis. II Hematogenous infection at the junction of the burn wound and the unburned hypodermis. J Surg Res. 1964;4:217-22.
63. Teplitz C, Davis D, Mason Jr AD, Moncrief JA. Pseudomonas burn wound sepsis. I Pathogenesis of experimental pseudomonas burn wound sepsis. J Surg Res. 1964;4:200-16.
64. Coban YK. Infection control in severely burned patients. World J Crit Care Med. 2012;1:94-101.
65. Branski LK, Al-Mousawi A, Rivero H, Jeschke MG, Sanford AP, Herndon DN. Emerging infections in burns. Surg Infect. 2009;10:389-97.
66. Shupp JW, Pavlovich AR, Jeng JC, Pezzullo JC, Oetgen WJ, Jaskille AD, et al. Epidemiology of bloodstream infections in burn-injured patients: a review of the national burn repository. J Burn Care Res. 2010;31:521-8.
67. Bloemsma GC, Dokter J, Boxma H, Oen IM. Mortality and causes of death in a burn centre. Burns. 2008;34:1103-7.
68. Chipp E, Milner CS, Blackburn AV. Sepsis in burns: a review of current practice and future therapies. Ann Plastic Surg. 2010;65:228-36.
69. Williams FN, Herndon DN, Hawkins HK, Lee JO, Cox RA, Kulp GA, et al. The leading causes of death after burn injury in a single pediatric burn center. Crit Care. 2009;13:R183.
70. Mann EA, Wood GL, Wade CE. Use of procalcitonin for the detection of sepsis in the critically ill burn patient: a systematic review of the literature. Burns. 2011;37:549-58.
71. Greenhalgh DG, Saffle JR, Holmes JH, Gamelli RL, Palmieri TL, Horton JW, et al. American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res. 2007;28:776-90.
72. D'Avignon LC, Chung KK, Saffle JR, Renz EM, Cancio LC. Prevention of Combat-Related Infections Guidelines Panel. Prevention of infections associated with combat-related burn injuries. J Trauma. 2011;71:S282-9.
73. D'Avignon LC, Hogan BK, Murray CK, Loo FL, Hospenthal DR, Cancio LC, et al. Contribution of bacterial and viral infections to attributable mortality in patients with severe burns: an autopsy series. Burns. 2010;36:773-9.
74. Hospenthal DR, Murray CK, Andersen RC, Bell RB, Calhoun JH, Cancio LC, et al. Guidelines for the prevention of infections associated with combat-related injuries: 2011 update: endorsed by the Infectious Diseases Society of America and the Surgical Infection Society. J Trauma. 2011;71:S210-34.
75. Hospenthal DR, Murray CK, Andersen RC, Blice JP, Calhoun JH, Cancio LC, et al. Guidelines for the prevention of infection after combat-related injuries. J Trauma. 2008;64:S211-20.
76. Rafla K, Tredget EE. Infection control in the burn unit. Burns. 2011;37:5-15.
77. Rowley-Conwy G. Infection prevention and treatment in patients with major burn injuries. Nurs Stand. 2010;25:51-2. 54, 56-8 passim.
78. Brown TP, Cancio LC, McManus AT, Mason Jr AD. Survival benefit conferred by topical antimicrobial preparations in burn patients: a historical perspective. J Trauma. 2004;56:863-6.
79. Roberts JA, Abdul-Aziz MH, Lipman J, Mouton JW, Vinks AA, Felton TW, et al. Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. Lancet Infect Dis. 2014;14:498-509.
80. Horvath EE, Murray CK, Vaughan GM, Chung KK, Hospenthal DR, Wade CE, et al. Fungal wound infection (not colonization) is independently associated with mortality in burn patients. Ann Surg. 2007;245:978-85.
81. Herndon DN, Tompkins RG. Support of the metabolic response to burn injury. Lancet. 2004;363:1895-902.
82. Williams FN, Herndon DN, Jeschke MG. The hypermetabolic response to burn injury and interventions to modify this response. Clin Plast Surg. 2009;36:583-96.
83. Andel H, Kamolz LP, Horauf K, Zimpfer M. Nutrition and anabolic agents in burned patients. Burns. 2003;29:592-5.
84. Abdullahi A, Jeschke MG. Nutrition and anabolic pharmacotherapies in the care of burn patients. Nutr Clin Pract. 2014;29:621-30.
85. Hart DW, Wolf SE, Chinkes DL, Beauford RB, Mlcak RP, Heggers JP, et al. Effects of early excision and aggressive enteral feeding on hypermetabolism, catabolism, and sepsis after severe burn. J Trauma. 2003;54:755-61. discussion 761-4.
86. Mosier MJ, Pham TN, Klein MB, Gibran NS, Arnoldo BD, Gamelli RL, et al. Early enteral nutrition in burns: compliance with guidelines and associated outcomes in a multicenter study. J Burn Care Res. 2011;32:104-9.
87. Mecott GA, Al-Mousawi AM, Gauglitz GG, Herndon DN, Jeschke MG. The role of hyperglycemia in burned patients: evidence-based studies. Shock. 2010;33:5-13.
88. Gore DC, Chinkes DL, Hart DW, Wolf SE, Herndon DN, Sanford AP. Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med. 2002;30:2438-42.
89. Kulp GA, Tilton RG, Herndon DN, Jeschke MG. Hyperglycemia exacerbates burn-induced liver inflammation via noncanonical nuclear factor-kappaB pathway activation. Mol Med. 2012;18:948-56.
90. Cunningham-Rundles S, McNeeley DF, Moon A. Mechanisms of nutrient modulation of the immune response. J Allergy Clin Immunol. 2005;115:1119-28. quiz 1129.
91. Schwacha MG, Chaudry IH. The cellular basis of post-burn immunosuppression: macrophages and mediators. Int J Mol Med. 2002;10:239-43.
92. Ferrando AA, Chinkes DL, Wolf SE, Matin S, Herndon DN, Wolfe RR. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg. 1999;229:11-8.
93. Hrynyk M, Neufeld RJ. Insulin and wound healing. Burns. 2014;40:1433-46.
94. Pidcoke HF, Baer LA, Wu X, Wolf SE, Aden JK, Wade CE. Insulin effects on glucose tolerance, hypermetabolic response, and circadian-metabolic protein expression in a rat burn and disuse model. Am J Physiol Regul Integr Comp Physiol. 2014;307:R1-10.
95. Pidcoke HF, Wade CE, Wolf SE. Insulin and the burned patient. Crit Care Med. 2007;35:S524-30.
96. Sakurai Y, Aarsland A, Herndon DN, Chinkes DL, Pierre E, Nguyen TT, et al. Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann Surg. 1995;222:283-94.
97. Hart DW, Wolf SE, Ramzy PI, Chinkes DL, Beauford RB, Ferrando AA, et al. Anabolic effects of oxandrolone after severe burn. Ann Surg. 2001;233:556-64.
98. Tuvdendorj D, Chinkes DL, Zhang XJ, Suman OE, Aarsland A, Ferrando A, et al. Long-term oxandrolone treatment increases muscle protein net deposition via improving amino acid utilization in pediatric patients 6 months after burn injury. Surgery. 2011;149:645-53.
99. Wolf SE, Edelman LS, Kemalyan N, Donison L, Cross J, Underwood M, et al. Effects of oxandrolone on outcome measures in the severely burned: a multicenter prospective randomized double-blind trial. J Burn Care Res. 2006;27:131-9. discussion 140-1.
100. Wolf SE, Thomas SJ, Dasu MR, Ferrando AA, Chinkes DL, Wolfe RR, et al. Improved net protein balance, lean mass, and gene expression changes with oxandrolone treatment in the severely burned. Ann Surg. 2003;237:801-10. discussion 810-1.
101. Bains JW, Crawford DT, Ketcham AS. Effect of chronic anemia on wound tensile strength: correlation with blood volume, total red blood cell volume and proteins. Ann Surg. 1966;164:243-6.
102. Agarwal P, Prajapati B, Sharma D. Evaluation of skin graft take following post-burn raw area in normovolaemic anaemia. Indian J Plast Surg. 2009;42:195-8.
103. Namdar T, Stollwerck PL, Stang FH, Eisenbeiss W, Siemers F, Mailander P, et al. Impact of hypernatremia on burn wound healing: results of an exploratory, retrospective study. Ostomy Wound Manage. 2011;57:30-4.
104. Nitzschke SL, Aden JK, Serio-Melvin ML, Shingleton SK, Chung KK, Waters JA, et al. Wound healing trajectories in burn patients and their impact on mortality. J Burn Care Res. 2014;35:474-9.
105. Desai MH, Herndon DN, Broemeling L, Barrow RE, Nichols Jr RJ, Rutan RL. Early burn wound excision significantly reduces blood loss. Ann Surg. 1990;211:753-9. discussion 759-62.
106. Herndon DN, Barrow RE, Rutan RL, Rutan TC, Desai MH, Abston S. A comparison of conservative versus early excision. Therapies in severely burned patients. Ann Surg. 1989;209:547-52. discussion 552-3.
107. Saaiq M, Zaib S, Ahmad S. Early excision and grafting versus delayed excision and grafting of deep thermal burns up to 40 % total body surface area: a comparison of outcome. Ann Burns Fire Disasters. 2012;25:143-7.
108. Vinita P, Khare NA, Chandramouli M, Nilesh S, Sumit B. Comparative analysis of early excision and grafting vs delayed grafting in burn patients in a developing country. J Burn Care Res. 2014; doi:10.1097/BCR.0b013e31827e4ed6.
109. Ong YS, Samuel M, Song C. Meta-analysis of early excision of burns. Burns. 2006;32:145-50.
110. Schwanholt C, Greenhalgh DG, Warden GD. A comparison of full-thickness versus split-thickness autografts for the coverage of deep palm burns in the very young pediatric patient. J Burn Care Rehab. 1993;14:29-33.
111. Akan M, Yildirim S, Misirlioglu A, Ulusoy G, Akoz T, Avci G. An alternative method to minimize pain in the split-thickness skin graft donor site. Plast Reconstruct Surg. 2003;111:2243-9.
112. Voineskos SH, Ayeni OA, McKnight L, Thoma A. Systematic review of skin graft donor-site dressings. Plast Reconstruct Surg. 2009;124:298-306.
113. Hermans MH. Preservation methods of allografts and their (lack of) influence on clinical results in partial thickness burns. Burns. 2011;37:873-81.
114. Hermans MH. Porcine xenografts vs. (cryopreserved) allografts in the management of partial thickness burns: is there a clinical difference? Burns. 2014;40:408-15.
115. Ehrenreich M, Ruszczak Z. Tissue-engineered temporary wound coverings. Important options for the clinician. Acta Dermatovenerol Alp Pannonica Adriat. 2006;15:5-13.
116. Ehrenreich M, Ruszczak Z. Update on tissue-engineered biological dressings. Tissue Eng. 2006;12:2407-24.
117. Groeber F, Holeiter M, Hampel M, Hinderer S, Schenke-Layland K. Skin tissue engineering - in vivo and in vitro applications. Clin Plast Surg. 2012;39:33-58.
118. Mansbridge J. Skin tissue engineering. J Biomater Sci Polym Ed. 2008;19:955-68.
119. Mansbridge JN. Tissue-engineered skin substitutes in regenerative medicine. Curr Opin Biotechnol. 2009;20:563-7.
120. Catalano E, Cochis A, Varoni E, Rimondini L, Azzimonti B. Tissue-engineered skin substitutes: an overview. J Artif. 2013;16:397-403.
121. Shevchenko RV, James SL, James SE. A review of tissue-engineered skin bioconstructs available for skin reconstruction. J R Soc Interface. 2010;7:229-58.
122. Atiyeh BS, Costagliola M. Cultured epithelial autograft (CEA) in burn treatment: three decades later. Burns. 2007;33:405-13.
123. Fang T, Lineaweaver WC, Sailes FC, Kisner C, Zhang F. Clinical application of cultured epithelial autografts on acellular dermal matrices in the treatment of extended burn injuries. Ann Plast Surg. 2014;73:509-15.
124. Jeschke MG, Finnerty CC, Shahrokhi S, Branski LK, Dibildox M, Organization ABA, et al. Wound coverage technologies in burn care: novel techniques. J Burn Care Res. 2013;34:612-20.
125. Supp DM, Boyce ST. Engineered skin substitutes: practices and potentials. Clin Dermatol. 2005;23:403-12.
126. Kampmann A, Lindhorst D, Schumann P, Zimmerer R, Kokemuller H, Rucker M, et al. Additive effect of mesenchymal stem cells and VEGF to vascularization of PLGA scaffolds. Microvasc Res. 2013;90:71-9.
127. Park KM, Gerecht S. Harnessing developmental processes for vascular engineering and regeneration. Development. 2014;141:2760-9.
128. Broussard KC, Powers JG. Wound dressings: selecting the most appropriate type. Am J Clin Dermatol. 2013;14:449-59.
129. Wasiak J, Cleland H, Campbell F, Spinks A. Dressings for superficial and partial thickness burns. Cochrane Database Syst Rev. 2013;3, CD002106.
130. Aziz Z, Abu SF, Chong NJ. A systematic review of silver-containing dressings and topical silver agents (used with dressings) for burn wounds. Burns. 2012;38:307-18.
131. Nikkhah D, Gilbert P, Booth S, Dheansa B. Should we be using silver based compounds for donor site dressing in thermal burns? Burns. 2013;39:1324-5.
132. Abboud EC, Legare TB, Settle JC, Boubekri AM, Barillo DJ, Marcet JE, et al. Do silver-based wound dressings reduce pain? A prospective study and review of the literature. Burns. 2014;40:S40-7.
133. Navarro FA, Stoner ML, Park CS, Huertas JC, Lee HB, Wood FM, et al. Sprayed keratinocyte suspensions accelerate epidermal coverage in a porcine microwound model. J Burn Care Rehab. 2000;21:513-8.
134. Wood FM, Kolybaba ML, Allen P. The use of cultured epithelial autograft in the treatment of major burn wounds: eleven years of clinical experience. Burns. 2006;32:538-44.
135. Wood FM, Kolybaba ML, Allen P. The use of cultured epithelial autograft in the treatment of major burn injuries: a critical review of the literature. Burns. 2006;32:395-401.
136. Tenenhaus M, Rennekampff HO. Surgical advances in burn and reconstructive plastic surgery: new and emerging technologies. Clin Plast Surg. 2012;39:435-43.
137. Tausche AK, Skaria M, Bohlen L, Liebold K, Hafner J, Friedlein H, et al. An autologous epidermal equivalent tissue-engineered from follicular outer root sheath keratinocytes is as effective as split-thickness skin autograft in recalcitrant vascular leg ulcers. Wound Repair Regen. 2003;11:248-52.
138. Bisson F, Rochefort E, Lavoie A, Larouche D, Zaniolo K, Simard-Bisson C, et al. Irradiated human dermal fibroblasts are as efficient as mouse fibroblasts as a feeder layer to improve human epidermal cell culture lifespan. Int J Mol Sci. 2013;14:4684-704.
139. Idrus RB, Rameli MA, Low KC, Law JX, Chua KH, Latiff MB, et al. Full-thickness skin wound healing using autologous keratinocytes and dermal fibroblasts with fibrin: bilayered versus single-layered substitute. Adv Skin Wound Care. 2014;27:171-80.
140. Auxenfans C, Menet V, Catherine Z, Shipkov H, Lacroix P, Bertin-Maghit M, et al. Cultured autologous keratinocytes in the treatment of large and deep burns: a retrospective study over 15 years. Burns. 2015;41:71-9.
141. Auxenfans C, Shipkov H, Bach C, Catherine Z, Lacroix P, Bertin-Maghit M, et al. Cultured allogenic keratinocytes for extensive burns: a retrospective study over 15 years. Burns. 2014;40:82-8.
142. van der Veer WM, Bloemen MC, Ulrich MM, Molema G, van Zuijlen PP, Middelkoop E, et al. Potential cellular and molecular causes of hypertrophic scar formation. Burns. 2009;35:15-29.
143. Lewis CJ. Stem cell application in acute burn care and reconstruction. J Wound Care. 2013;22:7-8. 10, 12-6.
144. Badiavas EV. The potential of bone marrow cells to orchestrate homeostasis and healing in skin. Blood Cells Mol Dis. 2004;32:21-3.
145. Badiavas EV, Abedi M, Butmarc J, Falanga V, Quesenberry P. Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol. 2003;196:245-50.
146. Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol. 2008;180:2581-7.
147. Bey E, Prat M, Duhamel P, Benderitter M, Brachet M, Trompier F, et al. Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations. Wound Repair Regen. 2010;18:50-8.
148. Kim WS, Park BS, Sung JH, Yang JM, Park SB, Kwak SJ, et al. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci. 2007;48:15-24.
149. Nakagami H, Maeda K, Morishita R, Iguchi S, Nishikawa T, Takami Y, et al. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol. 2005;25:2542-7.
150. Kurata S, Itami S, Terashi H, Takayasu S. Successful transplantation of cultured human outer root sheath cells as epithelium. Ann Plast Surg. 1994;33:290-4.
151. Navsaria HA, Ojeh NO, Moiemen N, Griffiths MA, Frame JD. Reepithelialization of a full-thickness burn from stem cells of hair follicles micrografted into a tissue-engineered dermal template (Integra). Plast Reconstruct Surg. 2004;113:978-81.
152. Trottier V, Marceau-Fortier G, Germain L, Vincent C, Fradette J. IFATS collection: using human adipose-derived stem/stromal cells for the production of new skin substitutes. Stem Cells. 2008;26:2713-23.
153. Natesan S, Wrice NL, Baer DG, Christy RJ. Debrided skin as a source of autologous stem cells for wound repair. Stem Cells. 2011;29:1219-30.
154. Chan RK, Zamora DO, Wrice NL, Baer DG, Renz EM, Christy RJ, et al. Development of a vascularized skin construct using adipose-derived stem cells from debrided burned skin. Stem Cells Int. 2012;2012:841203.
155. Williams JF, King BT, Aden JK, Serio-Melvin M, Chung KK, Fenrich CA, et al. Comparison of traditional burn wound mapping with a computerized program. J Burn Care Res. 2013;34:e29-35.
156. Brown TS, Safford S, Caramanica J, Elster EA. Biomarker use in tailored combat casualty care. Biomark Med. 2010;4:465-73.
157. Hawksworth JS, Stojadinovic A, Gage FA, Tadaki DK, Perdue PW, Forsberg J, et al. Inflammatory biomarkers in combat wound healing. Ann Surg. 2009;250:1002-7.
158. Hahm G, Glaser JJ, Elster EA. Biomarkers to predict wound healing: the future of complex war wound management. Plast Reconstruct Surg. 2011;127:21S-6S.
159. Chromy BA, Eldridge A, Forsberg JA, Brown TS, Kirkup BC, Elster E, et al. Proteomic sample preparation for blast wound characterization. Proteome Sci. 2014;12:10.
160. Chromy BA, Eldridge A, Forsberg JA, Brown TS, Kirkup BC, Jaing C, et al. Wound outcome in combat injuries is associated with a unique set of protein biomarkers. J Transl Med. 2013;11:281.
161. Forsberg JA, Potter BK, Polfer EM, Safford SD, Elster EA. Do inflammatory markers portend heterotopic ossification and wound failure in combat wounds? Clin Orthop Relat Res. 2014;472:2845-54.
162. Mikhal'chik EV, Piterskaya JA, Budkevich LY, Pen'kov LY, Facchiano A, De Luca C, et al. Comparative study of cytokine content in the plasma and wound exudate from children with severe burns. Bull Exp Biol Med. 2009;148:771-5.
163. Widgerow AD, King K, Tussardi IT, Banyard DA, Chiang R, Awad A, et al. The burn wound exudate - an under-utilized resource. Burns. 2015;41:11-7.
164. Prager MD, Sabeh F, Baxter CR, Atiles L, Hartline B. Dipeptidyl peptidase IV and aminopeptidase in burn wound exudates: implications for wound healing. J Trauma. 1994;36:629-33.
165. Mauskar NA, Sood S, Travis TE, Matt SE, Mino MJ, Burnett MS, et al. Donor site healing dynamics: molecular, histological, and noninvasive imaging assessment in a porcine model. J Burn Care Res. 2013;34:549-62.
166. Kaiser M, Yafi A, Cinat M, Choi B, Durkin AJ. Noninvasive assessment of burn wound severity using optical technology: a review of current and future modalities. Burns. 2011;37:377-86.
167. Arbab MH, Dickey TC, Winebrenner DP, Chen A, Klein MB, Mourad PD. Terahertz reflectometry of burn wounds in a rat model. Biomed Opt Express. 2011;2:2339-47.
168. Cross KM, Leonardi L, Gomez M, Freisen JR, Levasseur MA, Schattka BJ, et al. Noninvasive measurement of edema in partial thickness burn wounds. J Burn Care Res. 2009;30:807-17.
169. Cross KM, Leonardi L, Payette JR, Gomez M, Levasseur MA, Schattka BJ, et al. Clinical utilization of near-infrared spectroscopy devices for burn depth assessment. Wound Repair Regen. 2007;15:332-40.
170. Nguyen JQ, Crouzet C, Mai T, Riola K, Uchitel D, Liaw LH, et al. Spatial frequency domain imaging of burn wounds in a preclinical model of graded burn severity. J Biomed Opt. 2013;18:66010.
171. Sowa MG, Leonardi L, Payette JR, Cross KM, Gomez M, Fish JS. Classification of burn injuries using near-infrared spectroscopy. J Biomed Opt. 2006;11:054002.
172. Sowa MG, Leonardi L, Payette JR, Fish JS, Mantsch HH. Near infrared spectroscopic assessment of hemodynamic changes in the early post-burn period. Burns. 2001;27:241-9.
173. Devgan L, Bhat S, Aylward S, Spence RJ. Modalities for the assessment of burn wound depth. J Burns Wounds. 2006;5, e2.
174. Pape SA, Skouras CA, Byrne PO. An audit of the use of laser Doppler imaging (LDI) in the assessment of burns of intermediate depth. Burns. 2001;27:233-9.
175. Hoeksema H, Van de Sijpe K, Tondu T, Hamdi M, Van Landuyt K, Blondeel P, et al. Accuracy of early burn depth assessment by laser Doppler imaging on different days post burn. Burns. 2009;35:36-45.
176. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA. 2014;311:806-14.
177. Goutos I, Sadideen H, Pandya AA, Ghosh SJ. Obesity and burns. J Burn Care Res. 2012;33:471-82.
178. Neaman KC, Andres LA, McClure AM, Burton ME, Kemmeter PR, Ford RD. A new method for estimation of involved BSAs for obese and normal-weight patients with burn injury. J Burn Care Res. 2011;32:421-8.
179. Liodaki E, Senyaman O, Stollwerck PL, Mollmeier D, Mauss KL, Mailander P, et al. Obese patients in a burn care unit: a major challenge. Burns. 2014;40:1738-42.
180. Keck M, Lumenta DB, Andel H, Kamolz LP, Frey M. Burn treatment in the elderly. Burns. 2009;35:1071-9.
181. Lewandowski R, Pegg S, Fortier K, Skimmings A. Burn injuries in the elderly. Burns. 1993;19:513-5.
182. Hunt JL, Purdue GF. The elderly burn patient. Am J Surg. 1992;164:472-6.
183. Williams GJ, Herndon DN. Modulating the hypermetabolic response to burn injuries. J Wound Care. 2002;11:87-9.
184. Roberts G, Lloyd M, Parker M, Martin R, Philp B, Shelley O, et al. The Baux score is dead. Long live the Baux score: a 27-year retrospective cohort study of mortality at a regional burns service. J Trauma Acute Care Surg. 2012;72:251-6.
185. Nordlund MJ, Pham TN, Gibran NS. Micronutrients after burn injury: a review. J Burn Care Res. 2014;35:121-33.
186. Pintaudi AM, Tesoriere L, D'Arpa N, D'Amelio L, D'Arpa D, Bongiorno A, et al. Oxidative stress after moderate to extensive burning in humans. Free Radic Res. 2000;33:139-46.
187. Vinha PP, Martinez EZ, Vannucchi H, Marchini JS, Farina Jr JA, Jordao Jr AA, et al. Effect of acute thermal injury in status of serum vitamins, inflammatory markers, and oxidative stress markers: preliminary data. J Burn Care Res. 2013;34:e87-91.
188. Aida T, Murata J, Asano G, Kanda Y, Yoshino Y. Effects of polyprenoic acid on thermal injury. Br J Exp Pathol. 1987;68:351-8.
189. Nickle SB, Peterson N, Peterson M. Updated physician's guide to the off-label uses of oral isotretinoin. J Clin Aesthet Dermatol. 2014;7:22-34.
190. Dematte MF, Gemperli R, Salles AG, Dolhnikoff M, Lancas T, Saldiva PH, et al. Mechanical evaluation of the resistance and elastance of post-burn scars after topical treatment with tretinoin. Clinics. 2011;66:1949-54.
191. Salles AG, Gemperli R, Toledo PN, Ferreira MC. Combined tretinoin and glycolic acid treatment improves mouth opening for postburn patients. Aesthet Plast Surg. 2006;30:356-62.
192. Macias-Barragan J, Sandoval-Rodriguez A, Navarro-Partida J, Armendariz-Borunda J. The multifaceted role of pirfenidone and its novel targets. Fibrogenesis Tissue Repair. 2010;3:16.
193. Jung KI, Choi JS, Kim HK, Shin SY. Effects of an anti-transforming growth factor-beta agent (pirfenidone) on strabismus surgery in rabbits. Curr Eye Res. 2012;37:770-6.
194. Zhong H, Sun G, Lin X, Wu K, Yu M. Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery. Invest Ophthalmol Vis Sci. 2011;52:3136-42.
195. Chowdhury S, Guha R, Trivedi R, Kompella UB, Konar A, Hazra S. Pirfenidone nanoparticles improve corneal wound healing and prevent scarring following alkali burn. PLoS One. 2013;8, e70528.
196. Cianci P, Sato R. Adjunctive hyperbaric oxygen therapy in the treatment of thermal burns: a review. Burns. 1994;20:5-14.
197. Cianci P, Williams C, Lueders H, Lee H, Shapiro R, Sexton J, et al. Adjunctive hyperbaric oxygen in the treatment of thermal burns. An economic analysis. J Burn Care Rehab. 1990;11:140-3.
198. Selcuk CT, Ozalp B, Durgun M, Tekin A, Akkoc MF, Alabalik U, et al. The effect of hyperbaric oxygen treatment on the healing of burn wounds in nicotinized and nonnicotinized rats. J Burn Care Res. 2013;34:e237-43.
199. Cianci P, Slade Jr JB, Sato RM, Faulkner J. Adjunctive hyperbaric oxygen therapy in the treatment of thermal burns. Undersea Hyperb Med. 2013;40:89-108.
200. Eskes A, Vermeulen H, Lucas C, Ubbink DT. Hyperbaric oxygen therapy for treating acute surgical and traumatic wounds. Cochrane Database Syst Rev. 2013;12, CD008059.
201. Eskes AM, Ubbink DT, Lubbers MJ, Lucas C, Vermeulen H. Hyperbaric oxygen therapy: solution for difficult to heal acute wounds? Systematic review. World J Surg. 2011;35:535-42.
202. Wolf SE, Tompkins RG, Herndon DN. On the horizon: research priorities in burns for the next decade. Surg Clin North Am. 2014;94:917-30.